- Filed
- Nov 18, 2024 12:00 AM ET
- Period of report
- —
Amendment.
Amends a previously filed report.
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2023 · Apr 28, 2023 | 55.68M sh |
| Cash And Equivalents | Q1 2023 · Mar 31, 2023 | $516.61M |
| Cash And Equivalents | Q1 2023 · Dec 31, 2022 | $523.46M |
| Stockholders Equity restated | Q1 2023 · Mar 31, 2023 | $1.93B |
| Stockholders Equity | Q1 2023 · Dec 31, 2022 | $1.91B |
| Stockholders Equity | Q1 2023 · Mar 31, 2022 | $1.77B |
| Stockholders Equity | Q1 2023 · Dec 31, 2021 | $1.75B |
| Current Liabilities restated | Q1 2023 · Mar 31, 2023 | $416.56M |
| Current Liabilities | Q1 2023 · Dec 31, 2022 | $404.2M |
| Total Liabilities restated | Q1 2023 · Mar 31, 2023 | $621.23M |
| Total Liabilities restated | Q1 2023 · Dec 31, 2022 | $620.9M |
| Current Assets restated | Q1 2023 · Mar 31, 2023 | $1.02B |
| Current Assets | Q1 2023 · Dec 31, 2022 | $998.12M |
| Total Assets restated | Q1 2023 · Mar 31, 2023 | $2.55B |
| Total Assets restated | Q1 2023 · Dec 31, 2022 | $2.53B |
| Shares Diluted | Q1 2023 · Mar 31, 2022 | 58.82K sh |
| Capex | Q1 2023 · Mar 31, 2022 | $27.2M |
| Operating Cash Flow | Q1 2023 · Mar 31, 2022 | $23.11M |
| Eps Diluted | Q1 2023 · Mar 31, 2022 | $0.81 |
| Eps Basic | Q1 2023 · Mar 31, 2022 | $0.85 |
| Sga Expense | Q1 2023 · Mar 31, 2022 | $54.3M |
| Rd Expense | Q1 2023 · Mar 31, 2022 | $12.16M |
| Net Income | Q1 2023 · Mar 31, 2022 | $46.96M |
| Operating Income | Q1 2023 · Mar 31, 2022 | $60M |
| Cost Of Revenue | Q1 2023 · Mar 31, 2022 | $82.36M |